Monthly Injectable BUP for MA Use Disorder (MURB) Trial

Summary

This study is a 12-week randomized, double-blind, placebo-controlled trial that will investigate the use of injectable buprenorphine (BUP-Inj) compared to injectable placebo (PBO-Inj) for the treatment of methamphetamine use disorder (MUD) among individuals with mild co-use of opioids.

Timeline

Start

2023-03-24

Primary completion

2023-10-20

Completion

2023-11-19

Drugs

Indications